Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Wants a Proteomics Machine on Every Desktop, but First a Partner to Make it Happen

SAN FRANCISCO, Jan. 10 - Norrie Russell, CEO of Lynx Therapeutics, wants to put a proteomics machine on every desktop.


"The foundation technology for proteomics is gel electrophoresis, which is not sensitive enough, not reproducible, and takes forever to do," Russell said on Thursday at the 20th annual JPMorgan H&Q Healthcare Conference, which ended today.


"[Our] philosophy is to decentralize proteomics," he said. "The challenge to the engineers: make it [sit] on a desktop, inexpensive, and easy to use. Every laboratory can have one of these."


Lynx's Protein ProFiler, a 2-D solution-phase separation technology using a micro-channel glass plate, is 12 to 18 months away from coming to market, Russell said.


Except for one thing: the company needs a development partner.


"[We're looking for] someone who already makes instruments," Russell explained.


Russell would not reveal names of possible partners for the marketing and distributing deal, though he said it would be a company such as Agilent or Applied Biosystems. "These kind of guys," said Russell.


Russell did name names in another deal: Celera will be including Lynx's gene expression data on the Celera Discovery System within the next two months, said Russell. Lynx's database contains 54 million data points from 30 samples of normal human tissue, he said.


Russell would not reveal the financial terms of the agreement.


The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.